Delivery Order SPE2DR25D3017-SPE2DR26F3EJ3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $4,737.30, with completion scheduled for December 1, 2025. This non-competitive delivery order represents a pharmaceutical procurement supporting federal medical supply needs, with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $18,079.54 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract, which is not set-aside, carries a firm fixed price structure with an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $19,435.63 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $34,205.63 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on December 3, 2025, with an ultimate completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $11,566.81 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on November 5, 2025, with an ultimate completion date of November 6, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,429.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on November 24, 2025, with completion scheduled for November 25, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $23,263.96. The award was executed on November 3, 2025, with an ultimate completion date of November 4, 2025, with no set-aside designation applied. Performance will be conducted from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $11,743.92, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through...
- The Defense Logistics Agency awarded a $43,288.13 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on June 6, 2025, with an ultimate completion date of June 9, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is executed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract constitutes a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3EJ3Delivery Order
The Defense Logistics Agency awarded a $34,327.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on December 5, 2025, with an ultimate completion date of December 8, 2025. This is an unset-aside, competitively awarded contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of diverse pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse medical supply requirements, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies, consistently through competitively awarded delivery orders with firm fixed pricing. This award of Jardiance—an oral antidiabetic medication—reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare systems through the DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.3k | 12/4/25 |